Menu Search
Equities

Faes Farma SA

FAE:MCE

Faes Farma SA

Actions
  • Price (EUR)3.45
  • Today's Change-0.025 / -0.72%
  • Shares traded165.60k
  • 1 Year change+10.24%
  • Beta0.5950
Data delayed at least 15 minutes, as of Nov 21 2024 16:35 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
Select bar for recommendation details.
Recommendations14-Nov-24
Buy0
Outperform1
Hold1
Sell2
Strong Sell0

Share price forecast in EUR

The 5 analysts offering 12 month price targets for FAES Farma SA have a median target of 4.00, with a high estimate of 4.60 and a low estimate of 3.20. The median estimate represents a 16.11% increase from the last price of 3.45.
High33.5%4.60
Med16.1%4.00
Low-7.1%3.20

Dividends in EUR

In 2023, Faes Farma SA reported a dividend of 0.16 EUR. The 4 analysts covering the company expect dividends of 0.13 EUR for the upcoming fiscal year, a decrease of 14.19%.
Div growth (TTM)--
More ▼

Earnings history & estimates in EUR

On Oct 24, 2019, earnings of 0.056 per share.
The next earnings announcement is expected on Feb 25, 2025.
Average growth rate+9.83%
FAES Farma SA reported annual 2023 earnings of 0.300 per share on Feb 27, 2024.
Average growth rate+9.41%
More ▼

Revenue history & estimates in EUR

Faes Farma, S.A. had 3rd quarter 2024 revenues of 119.26m. This bettered the 117.00m estimate of the one analyst covering the company. This was 0.68% above the prior year's 3rd quarter results.
Average growth rate-0.08%
Faes Farma, S.A. had revenues for the full year 2023 of 451.17m. This was 2.83% above the prior year's results.
Average growth rate+4.24%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.